Nventa Pharmaceuticals Corp.
Corporate Information Research & Development PipelineInvestor Relations
             
    Corporate ProfileManagement TeamBoard of DirectorsScientific and Medical Advisory BoardCorporate GovernanceRequest InformationContact us    

Richard B. Lai Fatt, Ph.D.

Vice President, Corporate Development

Richard B. Lai Fatt, Ph.D., joined the Company as its Vice President of Corporate Development in June 2007.  Prior to Nventa, Richard was the Vice President of Corporate Development at Kalypsys, Inc.  Before Kalypsys, Richard served as Vice President, Business Development and Strategic Marketing at Isis Pharmaceuticals, where he secured several licensing and collaboration deals, including partnerships with Merck and Amgen.  Earlier in his career, Richard held various positions at DuPont Merck Pharmaceuticals, Schering-Plough International, Schering Canada and Lederle Pharmaceuticals.

Richard received his B.Sc. at the University of Miami, Florida, and his Ph.D. in biology at McMaster University, Hamilton, Ontario, Canada.

 


 
- -   - -   -
   
Nventa Biopharmaceuticals Corporation All Rights Reserved Copyright 2004-2008 -terms of use -|-sitemap-|-contact